Le Lézard
Classified in: Health, Science and technology
Subject: Personnel

Shattuck Labs Appoints Casi DeYoung as Chief Business Officer


Shattuck Labs, Inc. ("Shattuck"), a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARCtm) platform to develop a novel class of biologic medicines for the treatment of cancer and other diseases, today announced Casi DeYoung has joined the Company as Chief Business Officer.

"We are very pleased to have Casi join our leadership team. As Shattuck continues to advance our potentially transformative therapeutic approach for the treatment of cancer and other diseases, her demonstrated leadership in driving strategic transactions, building organizations, and advancing innovation will be instrumental in achieving our mission of improving the lives of patients," said Josiah Hornblower, Chairman and Chief Executive Officer of Shattuck.

"It is an exciting time to join Shattuck. The ongoing Phase 1 trial of SL-279252 and continued advancement of the ARCtm platform further establish the Company as a leader in the development of novel bi-functional fusion protein therapies," said Ms. DeYoung. "Shattuck has an expansive pipeline of exciting opportunities across multiple therapeutic areas, which makes us uniquely positioned to transform numerous treatment landscapes. I look forward to working with the executive team to continue to build a world-class drug discovery and development company."

Ms. DeYoung joins Shattuck from ImmuneSensor Therapeutics, where she was the Chief Operating Officer responsible for corporate strategy, start-up operations, intellectual property, oversight of the Company's first IND filing and the initiation of a first-in-human Phase 1 clinical trial. Previously, she held several senior leadership positions, including Chief Business Officer at Mirna Therapeutics, Vice President of Business Development at Reata Pharmaceuticals, Vice President of Business Development at ODC Therapy and Operations Director for Oncology at EMD Pharmaceuticals and Merck KGaA. Ms. DeYoung earned a B.S. in Chemistry, from Southwestern University and an M.B.A. from the McCombs School of Business at the University of Texas at Austin.

About Shattuck Labs, Inc.

Shattuck is a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARCtm) platform to develop a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and other diseases. Using its ARCtm platform, Shattuck is building a pipeline of therapeutics, that consolidate checkpoint blockade and TNF receptor agonists into single therapeutics to improve outcomes for patients. Shattuck has offices in Austin, Texas and Durham, North Carolina. For more information, please visit: http://www.shattucklabs.com.


These press releases may also interest you

at 08:30
Remote workers could stall their personal development and fall behind in crucial skills they need to do their jobs due to a loss of ?organic learning.' As social distancing measures tighten and employers delay plans to bring workers back to the...

at 08:25
Ligand Pharmaceuticals Incorporated today announced it has completed its tender offer for all outstanding shares of Pfenex Inc. for $437.5 million in cash, plus one non-transferable contingent value right (CVR) per share representing the right to...

at 08:23
Tweddle Group today launched its new Integrated Diagnostic Explorer software?or IDEx?to enable faster, more accurate diagnostics for a wide range of industries....

at 08:23
Mobile Experts just released the industry's first fully researched, comprehensive, unbiased forecast for Edge Computing. "Fully researched" means that this forecast is the result of twelve previous reports which examined specific business cases and...

at 08:20
Everseen, the Visual AItm company driving profitability for the world's largest retailers, today announces the hire of Josh Osmon as Vice President of Product Management. Osmon will work directly with Everseen's retail clients to tailor the company's...

at 08:20
Interplay Learning, the leading global provider of online and virtual reality technical training for the essential skilled trades, announced today its partnership with Home Builders Institute (HBI). Following a successful seven-month pilot program...



News published on 9 december 2019 at 08:35 and distributed by: